Clicky

Ascendis Pharma AS(A71) News

Date Title
Jul 25 Ascendis Pharma A/S (ASND) Delivers Positive Trial Results for Hypoparathyroidism Treatment
Jul 24 High Growth Tech Stocks In The US Market
Jul 24 High Growth Tech Stocks In The US For July 2025
Jul 23 High Growth Tech Stocks In US To Watch July 2025
Jul 23 US High Growth Tech Stocks To Watch In July 2025
Jul 22 Phase II and Phase III Catalyst Monitor: Q3 2025 Outlook Report - Upcoming FDA Decisions Drive Momentum in Biopharma with Key Catalysts Across GHD, PKU, Presbyopia, and Wet AMD Treatments
Jul 21 Exploring 3 High Growth Tech Stocks In The US Market
Jul 18 US High Growth Tech Stocks To Watch For Potential Gains
Jun 27 Exploring Three High Growth Tech Stocks In The US Market
Jun 27 Exploring 3 High Growth Tech Stocks in the US Market
Jun 26 Exploring High Growth Tech Stocks In The US Market
Jun 25 Exploring US High Growth Tech Stocks For Potential Opportunities
Jun 25 European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
Jun 25 US High Growth Tech Stocks To Watch In June 2025
Jun 24 High Growth Tech Stocks To Watch In US June 2025
Jun 24 Exploring US High Growth Tech Stocks To Watch In June 2025
Jun 24 Oppenheimer Hikes Ascendis Pharma Price Target on Strong Yorvipath Demand Outlook
Jun 23 High Growth Tech Stocks in US for June 2025
May 14 Ascendis Pharma A/S (ASND): Among the Best Growth Stocks to Buy and Hold for the Long Term
May 13 New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)